Insights

Rapid delivery MAYD specializes in near-instant medicine delivery with a 30 minute promise across multiple German cities and a broad catalog of over 5,000 healthcare-related goods, presenting a strong value proposition for urgent care and high-frequency pharmaceutical needs that sales teams can leverage to target time-sensitive customers and partnerships.

Europe expansion The company is actively building Europe’s healthcare platform for easier access to medication, indicating growth potential beyond current markets and opportunities to engage with cross-border logistics, pharmacy networks, and regional healthcare providers.

Strong funding With substantial seed and Series A backing totaling over $64M and marquee investors, MAYD has financial credibility to scale partnerships, invest in merchant onboarding, and pursue bundled service offers with clinics, insurers, and retail collaborators.

Tech-forward MAYD’s tech stack including Google Cloud Platform, ELK, Keycloak, and modern frontend frameworks suggests a mature digital commerce and analytics capability that can be leveraged to propose data-driven partnerships, integrated ordering, and white-label delivery solutions.

Market positioning Positioned as a door-to-door药 delivery platform with 365-day operations and a consultative approach, MAYD presents opportunities to upsell pharmacy products, chronic medication management, and value-added services to healthcare providers, employers, and patient communities seeking convenient, continuous access.

Similar companies to MAYD

MAYD Tech Stack

MAYD uses 8 technology products and services including Microsoft Advertising, HashiCorp Terraform, CircleCI, and more. Explore MAYD's tech stack below.

MAYD's Email Address Formats

MAYD uses at least 2 email formats:
MAYD Email FormatsExamplePercentage
First.Last@getmayd.comJohn.Doe@getmayd.com
97%
First.Middle@getmayd.comJohn.Michael@getmayd.com
3%

Frequently Asked Questions

What is MAYD's official website and social media links?

Minus sign iconPlus sign icon
MAYD's official website is getmayd.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does MAYD generate?

Minus sign iconPlus sign icon
As of August 2026, MAYD's annual revenue is estimated to be $1M - $10M.

What is MAYD's NAICS code?

Minus sign iconPlus sign icon
MAYD's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does MAYD have currently?

Minus sign iconPlus sign icon
As of August 2026, MAYD has approximately 36 employees across 2 continents, including Europe and North America. Key team members include Team Lead Mobile Engineer: A. H., City Manager: K. S. and Senior Backend Engineer: D. B. D. Á. Explore MAYD's employee directory with LeadIQ.

What industry does MAYD belong to?

Minus sign iconPlus sign icon
MAYD operates in the Pharmaceutical Manufacturing industry.

What technology does MAYD use?

Minus sign iconPlus sign icon
MAYD's tech stack includes Microsoft Advertising, HashiCorp Terraform, CircleCI, GitLab CI, Jenkins, Segment, Argo CD and Moz.

What is MAYD's email format?

Minus sign iconPlus sign icon
MAYD's email format typically follows the pattern of First.Last@getmayd.com. Find more MAYD email formats with LeadIQ.

How much funding has MAYD raised to date?

Minus sign iconPlus sign icon
As of August 2026, MAYD has raised $64M in funding. The last funding round occurred on Jan 27, 2022 for $33M.

When was MAYD founded?

Minus sign iconPlus sign icon
MAYD was founded in 2021.
MAYD logo

MAYD

Pharmaceutical ManufacturingBerlin, Germany11-50 Employees

MAYD is a Berlin-based pharmaceutical manufacturing company that operates a platform delivering medications to customers' doors within 30 minutes, every day of the year. It positions itself as building Europe's healthcare platform for easier access to medication, offering more than 5,000 healthcare-related goods. The business is located at 5 Alexanderstr. Berlin, Berlin 10178 Germany, and has a workforce of 11-50 employees. The company has secured external financing, including a Series A announced in January 2022. Its team comprises serial entrepreneurs and experienced operators, and the company has backing from investors.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2021
Employees
11-50

Section iconFunding & Financials

  • $64M

    MAYD has raised a total of $64M of funding over 3 rounds. Their latest funding round was raised on Jan 27, 2022 in the amount of $33M as a Series A.

  • $1M - $10M

    MAYD's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.